The company activity began from Innovita Research Foundation, a private foundation, which from 2001 was helping researchers working in the field of anti-aging medicine. At 2005 the foundation was re-structurized to Innovita Research company. During 16 years activity, Innovita Research performed and initiated a number of scientific projects in anti-aging medicine, immunotherapeutic approach for cancer treatment and regenerative medicine, which resulted in a number of scientific papers, patents and developed technologies.

RESEARCH AND DEVELOPMENT PROJECTS:

• Anti aging research - project “M”, mice lifespan prolongation with the use of cellular, subcellular and biopharmaceutical approach;

• Mitochondrial transfer technology - cellular mitochondrial transfer technology, preclinical investigation in vitro and in murine models;

• Anticancer research - xenogenic anticancer vaccine preclinical investigation in murine models.

TECHNOLOGIES:

• Cancer immunotherapy - the major goal of the immune system consists in maintenance of both internal environment and structural integrity of the body by providing anti-infectious protection and anticancer defense. In fact, the immune system is able to recognize abnormal tumorogenenic cells and to prevent their further uncontrolled growth.

• T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders - T-lymphocytes play a pivotal role in adaptive immunity. Pathogenic T cell activity is instrumental to the development of acquired immunological disorders. Self-reactive T lymphocytes able to attack host tissues induce autoimmune inflammation. High activity of allergen-specific T lymphocytes underlies the pathogenesis of allergic diseases.

• Adoptive cell-based immunotherapy for chronic inflammatory diseases - based on the introduction of activated (instructed) immune cells with a high microbicidal activity directly into the focus of a chronic infection. Recurrence of the disease may be an indication for a repeat procedure;

• OPI therapy for motor and skin diseases - OPI therapy is a complex treatment that simultaneously includes an orthokine (serum) therapy, a PrP (platelet) therapy and a leucocyte-based immunotherapy;

• Storage of immune cells - a technology of cell cryopreservation allows for application of healthy autologous immune cells when the protective abilities of the body are reduced as a consequence of aging or disease.

PRODUCTS:

• Cord blood plasma;
• Mesenchymal stem cells;
• Polyantigenic anticancer vaccine;
• Antitumor vaccines based on xenogeneic differentiation antigens;
• Cell lines;
• Cell-based products.

Innovita Research also offers high quality pre-clinical trials service of any kind of customer substance , device or technology.

Innovita Research

Org chart

Teams

Offices